Regulus has a research collaboration with the Samsung Biomedical Research Institute for testing anti-miR-10b development candidates in specialized preclinical models that mimic human brain cancer (Filing, S-1, Regulus, JUN 26, 2013, View Source [SID:1234503630])

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!